Study of pharmacological characteristics of antiretroviral drugs atazanavir/ritonavir and maraviroc in stable HIV-positive patients

Registry ID

EUCTR2014-004692-22

Source registry

EUCTR

Status

Ongoing

Phase

PHASE3

Sponsor

University of Torino

Start date

2015-11-19

Last update

2026-08-16

Conditions

• HIV infection

Summary

To describe pharmacokinetics of maraviroc 300 mg and atazanavir/ritonavir 200/100mg qd in HIV stable patients

Locations

• , , Italy

View on source registry